A clinical-stage protein manipulation company focused on hard to drug targets in Neuroscience, including Stroke, Parkinson's and ALS. Seeking Series A financing and partnerships to advance our assets . Our technology includes the ability to use peptides to block arbitrary protein-protein interactions, to degrade specific proteins, and to automatically deliver therapeutic peptides in emergency situations when medical assistance is unavailable.
Address
VancouverBC
Canada